此外,纳斯达克股票市场上市资格部还指出,Exicure未能举行2023年年度股东大会、以及按时提交2024年第一季度的10-Q表格同样违反了纳斯达克交易市场...查看全文
Exicure(XCUR)06-07 04:25
$Exicure(XCUR)$ 10-Q/A [Amend] Quarterly report [Sections 13 or 15(d)] Accession Number: 0001698530-24-000047 Act: 34 Size: 5 MB 网页链接查看全文
Exicure(XCUR)05-17 04:55
$Exicure(XCUR)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001698530-24-000029 Act: 34 Size: 247 KB 网页链接查看全文
Exicure(XCUR)07-03 06:15
$Exicure(XCUR)$ SC 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001193125-24-174435 Act: 34 Size: 64 KB 网页链接查看全文
蹊之美股生物医药2021-08-03 23:10
Gainers:
Infinity Pharmaceuticals (NASDAQ:INFI)+38%
Exicure (NASDAQ:XCUR) +34%
Ra Medical Systems (NYSE:RMED) +18%
Galmed Pharmaceuticals (NASDAQ:GLMD) +17%
Lava Therapeutics (NASDAQ:LVTX) +5%
Losers:
Immunovant (NASDAQ:IMVT) -26%...查看全文
chuminhua2021-08-03 17:17
8月2日,Ipsen 公司$IPSEN(IPSEY)$ 与Exicure公司$Exicure(XCUR)$ 达成了一项可能价值超过10亿美元的协议,开发球形核酸(SNA)作为亨廷顿病和安吉曼综合症的治疗方法,两家公司周一宣布。根据这项交易,Ipsen将向Exicure公司支付2000万美元的预付现金,并获得从这两个合作项目中获得治疗药物的独...查看全文
027-潇湘夜雨2021-08-02 19:59
$Exicure(XCUR)$ 两千万美金首付款不多,十亿美金的里程碑付款很诱人啊,市值才一亿美金@张小丰@矫首遐观@蹊之美股生物医药@Spica @黄建平 @青侨阳光 $美国生科ETF-SPDR(XBI)$查看全文
chuminhua2019-11-19 10:14
11/14,Exicure公司$Exicure(XCUR)$ 宣布,其与艾尔建(Allergan)$艾尔建医疗(AGN)$ 签订了一项全球合作协议。两家公司将利用Exicure专有的三维球形核酸(spherical nucleic acid,SNA)平台技术,开发2款治疗脱发的新疗法。依据协议条款,艾尔建将支付给Exicure公司2500万美金的预付款。届时若艾...查看全文
$Exicure(XCUR)$ SC 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001193125-24-174435 Act: 34 Size: 64 KB 网页链接
$Exicure(XCUR)$ 8-K Current report, items 5.07 and 9.01 Accession Number: 0001698530-24-000074 Act: 34 Size: 167 KB 网页链接
$Exicure(XCUR)$ 8-K Current report, items 3.01 and 9.01 Accession Number: 0001698530-24-000071 Act: 34 Size: 149 KB 网页链接
$Exicure(XCUR)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001698530-24-000068 Act: 34 Size: 5 MB 网页链接
$Exicure(XCUR)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001698530-24-000067 Act: 34 Size: 231 KB 网页链接
$Exicure(XCUR)$ ARS Annual Report to Security Holders Accession Number: 0001698530-24-000063 Act: 34 Size: 16 MB 网页链接
$Exicure(XCUR)$ DEF 14A Other definitive proxy statements Accession Number: 0001698530-24-000055 Act: 34 Size: 704 KB 网页链接
$Exicure(XCUR)$ 10-Q/A [Amend] Quarterly report [Sections 13 or 15(d)] Accession Number: 0001698530-24-000047 Act: 34 Size: 5 MB 网页链接
$Exicure(XCUR)$ 10-Q/A [Amend] Quarterly report [Sections 13 or 15(d)] Accession Number: 0001698530-24-000048 Act: 34 Size: 6 MB 网页链接
$Exicure(XCUR)$ 8-K Current report, items 2.02, 2.03, and 9.01 Accession Number: 0001698530-24-000049 Act: 34 Size: 231 KB 网页链接